Fierce Healthcare August 8, 2024
Pharmaceutical giant Roche bought health tech startup Flatiron Health for $1.9 billion in 2018 to expand its reach into real-world evidence and accelerate its development of cancer medicines.
Flatiron, once backed by Alphabet, built its business around oncology-focused electronic health record software and a repository of real-world cancer data. The company says it partners with hundreds of cancer centers and community oncology practices and more than 20 global developers of oncology therapeutics.
Flatiron, founded in 2012, set itself apart by pulling data out of hard-to-access sources and using them to build high-quality curated repositories.
ACCC to integrate Flatiron clinical trial tech into cancer center network
“This is an important step in our personalized healthcare strategy for Roche, as we...
Today's Sponsors
Today's Sponsor